Direct inhibition of thrombin may offer similar anticoagulant properties but also impact the underlying disease process. As we continue to gain experience and develop new DTIs, a new balance may ...

If walking is becoming difficult and physio isn’t working, cutting-edge treatments could be the next step. But which ones are ...

Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III ...

Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood ...

The global prothrombin complex concentrates market is on a strong upward trajectory, with projections indicating substantial growth in the coming decade. According to a recent report by Future Market ...

Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

Cerebral venous thrombosis is a rare but potentially life-threatening condition that is particularly prevalent in young women (ie, mean age 44 years) and accounts for 0·5–3% of all strokes. The ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three for oncology, a weekly insulin, and innovations in obesity, hemophilia, ...

Attribution (BY): Credit must be given to the creator. Percutaneous coronary intervention administration of statins enhances the thrombin–thrombomodulin (TM) interaction, which is critical for the ...